Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis

Author:

Kim Minsuk12,Vogtmann Emily3,Ahlquist David A.4,Devens Mary E.4,Kisiel John B.4,Taylor William R.4,White Bryan A.56,Hale Vanessa L.127,Sung Jaeyun128,Chia Nicholas12,Sinha Rashmi3,Chen Jun19

Affiliation:

1. Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA

2. Division of Surgical Research, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA

3. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA

5. Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA

6. Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA

7. Department of Veterinary Preventive Medicine, The Ohio State University College of Veterinary Medicine, Columbus, Ohio, USA

8. Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA

9. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA

Abstract

Colorectal adenomas are precursors of CRC. Recently, the gut microbiota, i.e., the collection of microbes residing in our gut, has been recognized as a key player in CRC development. There have been a number of gut microbiota profiling studies for colorectal adenoma and CRC; however, fewer studies have considered the gut metabolome, which serves as the chemical interface between the host and gut microbiota. Here, we conducted a gut metabolome profiling study of colorectal adenoma and CRC and analyzed the metabolomic profiles together with paired microbiota composition profiles. We found several chemical signatures of colorectal adenoma that were associated with some gut microbes and potentially indicative of future CRC. This study highlights potential early-driver metabolites in CRC pathogenesis and guides further targeted experiments and thus provides an important stepping stone toward developing better CRC prevention strategies.

Funder

Gerstner Family Career Development Award

Mark E. and Mary A. Davis to Mayo Clinic Center of Individualized Medicine

Intramural Research Program of the National Cancer Institute

Exact Sciences

HHS | NIH | National Cancer Institute

HHS | National Institutes of Health

Mayo Clinic

Mayo Clinic | Center for Individualized Medicine, Mayo Clinic

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3